Essentially, Ozempic and Wegovy are brand names for semaglutide, which is in the GLP-1 receptor agonist (GLP-1RA) drug class.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Mississippi Attorney General Lynn Fitch is warning Mississippians of unapproved and compounded weight loss drugs.

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

NO doubt you’ve heard the warnings. Drugs come with side effects – often unpleasant, dangerous, in rare cases ...

GLP-1 medications like Wegovy and Zepbound curb hunger, but can also cut out important nutrients from your diet. Here are ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

Arsenal Fan TV host Robbie Lyle has taken to social media to show off his weight loss progress by showing the clothes he used ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Weight loss pills either reduce appetite, boost metabolism or block fat absorption. Most people lose 5% to 10% of their body ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...